Health and Healthcare
Johnson & Johnson Earnings Point to New 52-Week High
Published:
Last Updated:
The company’s adjusted earnings excluded $300 million for a one-time tax benefit, partially offset by other charges. Adjusted net profit totaled $4.4 billion, up 7.8% year-over-year for the quarter.
J&J boosted its earnings guidance for the full year from an adjusted EPS range of $5.75 to $5.85 to a new range of $5.80 to $5.90. The consensus estimate had called for EPS of $5.83 on revenues of $74.22 billion.
The firm’s CEO said:
Johnson & Johnson delivered strong first-quarter results driven by successful new product launches and the continued growth of key products. … We also advanced our near-term priorities and long-term growth drivers, positioning us well to deliver sustainable results.
Worldwide consumer sales dropped 3.2% year over year to $3.6 billion, including a negative currency impact of 2.6%. Pharmaceutical sales rose 10.8% to $7.5 billion. Medical devices and diagnostics sales were flat at $7.1 billion. The negative currency exchange impact on total revenues was 1.8% in the quarter.
Primary contributors to the jump in pharmaceutical sales were the company’s psoriasis treatment, an antipsychotic for schizophrenia treatment, a treatment for HIV and new products, including its hepatitis C drug.
J&J has been one of the best performing stocks in the Dow Jones Industrials so far this year, up about 6%. Only drug maker Merck & Co. (NYSE: MRK) and heavy equipment maker Caterpillar Inc. (NYSE: CAT), up 11% and 13% respectively, are performing better. The DJIA is down about 2.3% year to date.
Shares traded about 2.2% higher in the premarket Tuesday, at $99.25 in a 52-week range of $82.07 to $99.38. Thomson Reuters had a consensus analyst price target of around $101.10 before the results were announced.
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.